Table 1. Baseline characteristics of included and non-included TB-patients with or without HIV a and healthy controls b .
| HIV+/TB patients | HIV-/TB patients c | Healthy controls (n = 31) | |||
|---|---|---|---|---|---|
| Included (n = 195) | Not included (n = 112) | Included (n = 170) | Not included (n = 639) | ||
| Age, median (IQR) | 32 (28–40) | 33 (28–40) | 30 (23–44) | 28 (22–42) | 22 (20–25) |
| Female gender, n (%) | 99 (51) | 52 (46) | 67 (39) | 310 (49) | 22 (71) |
| Smear positive pulmonary TB, n (%) | 62 (32) | 37 (33) | 75 (44) | 231 (36) | - |
| Smear negative pulmonary TB, n (%) | 62 (32) | 32 (29) | 43 (35) | 173 (27) | - |
| Extrapulmonary TB, n (%) d | 74 (38) | 49 (44) | 54 (32) | 244 (38) | - |
| BMI kg/m 2 (IQR) e | 17.5 (16–19.5) | 17.6 (16.1–19.5) | 18 (16.4–19.7) | 18.2 (16.5–20) | 21.6 (20.7–22.8) |
| MUAC cm (IQR) f | 21 (19–22) | 20 (19–22.4) | 21 (20–23) | 22 (20–23) | 24.5 (24–26.5) |
| CD4 count (cells/mm 3 ; median [IQR]) | 192 (106–344) | 150 (82–310) | 438 (323–688) | 715 (569–925) | 1022 (869–1118) |
a Total number of recruited subjects with active TB in the cohort was 1116
b Total number of recruited healthy controls in the cohort was 298
c All patients with CD4<500 cells/mm3 were selected for inclusion. For patients with CD4≥500cells/mm3 a consecutive number of patients were selected for inclusion.
d Patients could have a simultaneous diagnosis of extrapulmonary and pulmonary TB (included HIV+ patients, n = 3, included HIV-negative patients, n = 2).
e BMI is the calculated Body mass index (weight/height2).
f MUAC is the mid upper arm circumference measured by a measuring tape.